ArticleACS pharmacology & translational science2024

Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia

Alexander P Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.